{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:31:00Z","timestamp":1762867860868},"reference-count":65,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.10562","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T09:23:47Z","timestamp":1565083427000},"source":"Crossref","is-referenced-by-count":13,"title":["Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh\u20117 cells by regulating the ERK\u2011VEGF\/MMP9 signaling pathway"],"prefix":"10.3892","author":[{"given":"Yafei","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Tiantai People's Hospital, Taizhou, Zhejiang 317200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tiantai People's Hospital, Taizhou, Zhejiang 317200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tiantai People's Hospital, Taizhou, Zhejiang 317200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tiantai People's Hospital, Taizhou, Zhejiang 317200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"key20200713233740_b1-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.suronc.2017.01.009","article-title":"Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response","volume":"26","author":"Burkhart","year":"2017","journal-title":"Surg Oncol"},{"key":"key20200713233740_b2-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20200713233740_b3-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4329\/wjr.v5.i2.45","article-title":"Transcatheter arterial embolization for chest wall metastasis of hepatocellular carcinoma","volume":"5","author":"Nagao","year":"2013","journal-title":"World J Radiol"},{"key":"key20200713233740_b4-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/hep.26373","article-title":"MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"key20200713233740_b5-mmr-20-04-3317","first-page":"166","article-title":"TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis","volume":"3","author":"Germano","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"key":"key20200713233740_b6-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-3-319-55947-6_16","article-title":"Significance of EGFR expression in circulating tumor cells","volume":"994","author":"Serrano","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"key20200713233740_b7-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0092-8674(02)00966-2","article-title":"Ligand-induced, receptor-mediated dimerization and activation of EGF receptor","volume":"110","author":"Schlessinger","year":"2002","journal-title":"Cell"},{"key":"key20200713233740_b8-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"E30","DOI":"10.3390\/ijms17010030","article-title":"EGFR signaling in liver diseases","volume":"17","author":"Komposch","year":"2015","journal-title":"Int J Mol Sci"},{"key":"key20200713233740_b9-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.canlet.2018.11.006","article-title":"YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma","volume":"442","author":"Zhong","year":"2019","journal-title":"Cancer Lett"},{"key":"key20200713233740_b10-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12094-017-1761-8","article-title":"Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization","volume":"20","author":"Zhu","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"key20200713233740_b11-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11523-016-0465-2","article-title":"Afatinib: A review in advanced non-small cell lung cancer","volume":"11","author":"Keating","year":"2016","journal-title":"Target Oncol"},{"key":"key20200713233740_b12-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"key":"key20200713233740_b13-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12885-019-5605-5","article-title":"Numb inhibits epithelial-mesenchymal transition via RBP-J\u03ba-dependent Notch1\/PTEN\/FAK signaling pathway in tongue cancer","volume":"19","author":"Li","year":"2019","journal-title":"BMC Cancer"},{"key":"key20200713233740_b14-mmr-20-04-3317","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23028","article-title":"The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p\/metalloproteinases 3 axis","author":"Peng","year":"2019","journal-title":"Mol Carcinog"},{"key":"key20200713233740_b15-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.3390\/jcm5070065","article-title":"EMT in breast carcinoma-a review","volume":"5","author":"Felipe Lima","year":"2016","journal-title":"J Clin Med"},{"key":"key20200713233740_b16-mmr-20-04-3317","doi-asserted-by":"crossref","first-page":"22958","DOI":"10.1016\/S0021-9258(17)31603-4","article-title":"A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses","volume":"269","author":"Toh","year":"1994","journal-title":"J Biol Chem"},{"key":"key20200713233740_b17-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0378-1119(94)00410-T","article-title":"Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines","volume":"159","author":"Toh","year":"1995","journal-title":"Gene"},{"key":"key20200713233740_b18-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1023\/B:BREA.0000018421.31632.e6","article-title":"The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression","volume":"84","author":"Minard","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"key20200713233740_b19-mmr-20-04-3317","first-page":"48","article-title":"Tiam1, overexpressed in most malignancies, is a novel tumor biomarker","volume":"5","author":"Chen","year":"2012","journal-title":"Mol Med Rep"},{"key":"key20200713233740_b20-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"e73077","DOI":"10.1371\/journal.pone.0073077","article-title":"Tiam1 transgenic mice display increased tumor invasive and metastatic potential of colorectal cancer after 1,2-dimethylhydrazine treatment","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"key20200713233740_b21-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"key20200713233740_b22-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: Regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"key20200713233740_b23-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1172\/JCI6870","article-title":"Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention","volume":"103","author":"Stetler-Stevenson","year":"1999","journal-title":"J Clin Invest"},{"key":"key20200713233740_b24-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","article-title":"Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion","volume":"20","author":"Bourboulia","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"key20200713233740_b25-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neulet.2007.11.068","article-title":"p38 MAPK as a negative regulator of VEGF\/VEGFR2 signaling pathway in serum deprived human SK-N-SH neuroblastoma cells","volume":"431","author":"Gomes","year":"2008","journal-title":"Neurosci Lett"},{"key":"key20200713233740_b26-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.oraloncology.2005.11.002","article-title":"Activation of ERK1\/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: Relationship between clinicopathological appearances and cell proliferation","volume":"42","author":"Wang","year":"2006","journal-title":"Oral Oncol"},{"key":"key20200713233740_b27-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1756-9966-28-65","article-title":"Expression of phospho-ERK1\/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations","volume":"28","author":"Li","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"key20200713233740_b28-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1600-0625.2006.00511.x","article-title":"Enhancement of cell migration by corticotropin-releasing hormone through ERK1\/2 pathway in murine melanoma cell line, B16F10","volume":"16","author":"Yang","year":"2007","journal-title":"Exp Dermatol"},{"key":"key20200713233740_b29-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"40310","DOI":"10.18632\/oncotarget.5643","article-title":"Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion","volume":"6","author":"Henry","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713233740_b30-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00019606-200603000-00009","article-title":"Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts","volume":"15","author":"Arocho","year":"2006","journal-title":"Diagn Mol Pathol"},{"key":"key20200713233740_b31-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-016-0307-9","article-title":"Epithelial-to- mesenchymal plasticity of cancer stem cells: Therapeutic targets in hepatocellular carcinoma","volume":"9","author":"Jayachandran","year":"2016","journal-title":"J Hematol Oncol"},{"key":"key20200713233740_b32-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s11658-017-0053-1","article-title":"TGF-\u03b21-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin","volume":"22","author":"Wang","year":"2017","journal-title":"Cell Mol Biol Lett"},{"key":"key20200713233740_b33-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.2147\/CMAR.S195093","article-title":"The prognostic value of Tiam1 correlates with its roles in epithelial-mesenchymal transition progression and angiogenesis in lung adenocarcinoma","volume":"11","author":"Zhu","year":"2019","journal-title":"Cancer Manag Res"},{"key":"key20200713233740_b34-mmr-20-04-3317","doi-asserted-by":"crossref","first-page":"15966","DOI":"10.18632\/oncotarget.3862","article-title":"Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713233740_b35-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.yexmp.2017.05.009","article-title":"Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW1900 cells by targeting MTA1","volume":"102","author":"Lin","year":"2017","journal-title":"Exp Mol Pathol"},{"key":"key20200713233740_b36-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.phrs.2018.11.014","article-title":"Small molecule inhibitors targeting the EGFR\/ErbB family of protein-tyrosine kinases in human cancers","volume":"139","author":"Roskoski","year":"2019","journal-title":"Pharmacol Res"},{"key":"key20200713233740_b37-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1038\/onc.2017.230","article-title":"Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway","volume":"36","author":"Ding","year":"2017","journal-title":"Oncogene"},{"key":"key20200713233740_b38-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ccell.2016.07.017","article-title":"GOLM1 modulates EGFR\/RTK cell-surface recycling to drive hepatocellular carcinoma metastasis","volume":"30","author":"Ye","year":"2016","journal-title":"Cancer Cell"},{"key":"key20200713233740_b39-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","article-title":"The epidermal growth factor receptor pathway: A model for targeted therapy","volume":"12","author":"Scaltriti","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20200713233740_b40-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1634\/theoncologist.2017-0479","article-title":"Next-generation sequencing of circulating tumor DNA reveals frequent alterations in advanced hepatocellular carcinoma","volume":"23","author":"Ikeda","year":"2018","journal-title":"Oncologist"},{"key":"key20200713233740_b41-mmr-20-04-3317","doi-asserted-by":"crossref","first-page":"19354","DOI":"10.18632\/oncotarget.15223","article-title":"Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells","volume":"8","author":"Li","year":"2017","journal-title":"Oncotargt"},{"key":"key20200713233740_b42-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"171845","DOI":"10.1155\/2015\/171845","article-title":"Missense mutations in exons 18\u201324 of EGFR in hepatocellular carcinoma tissues","volume":"2015","author":"Panvichian","year":"2015","journal-title":"Biomed Res Int"},{"key":"key20200713233740_b43-mmr-20-04-3317","first-page":"280","article-title":"Dysfunctional uterine bleeding","volume":"169","author":"Chen","year":"1998","journal-title":"West J Med"},{"key":"key20200713233740_b44-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/jpet.112.197756","article-title":"Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker","volume":"343","author":"Solca","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"key20200713233740_b45-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.csbj.2018.10.016","article-title":"Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors","volume":"16","author":"Tu","year":"2018","journal-title":"Comput Struct Biotechnol J"},{"key":"key20200713233740_b46-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mce.2017.04.019","article-title":"Consider the context: Ras\/ERK and PI3K\/AKT\/mTOR signaling outcomes are pituitary cell type-specific","volume":"463","author":"Roof","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"key20200713233740_b47-mmr-20-04-3317","first-page":"1563","article-title":"Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells","volume":"6","author":"Fang","year":"2013","journal-title":"OncoTargets Ther"},{"key":"key20200713233740_b48-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cell.2010.01.017","article-title":"Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion","volume":"141","author":"Ishiyama","year":"2010","journal-title":"Cell"},{"key":"key20200713233740_b49-mmr-20-04-3317","first-page":"4274","article-title":"Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor\/scatter factor and its receptor, c-MET","volume":"9","author":"Jiang","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20200713233740_b50-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"key20200713233740_b51-mmr-20-04-3317","first-page":"2017","article-title":"Role of epithelial-mesenchymal transition in tumor progression","volume":"193","author":"Puisieux","year":"2009","journal-title":"Bull Acad Natl Med"},{"key":"key20200713233740_b52-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/hep.27911","article-title":"Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition","volume":"62","author":"Wang","year":"2015","journal-title":"Hepatology"},{"key":"key20200713233740_b53-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1038\/onc.2016.491","article-title":"MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"key":"key20200713233740_b54-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/cas.12749","article-title":"Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib","volume":"106","author":"Hashida","year":"2015","journal-title":"Cancer Sci"},{"key":"key20200713233740_b55-mmr-20-04-3317","first-page":"490","article-title":"Bufalin reverses hepatocyte growth factor-induced resistance to afatinib in H1975 lung cancer cells","volume":"37","author":"Kang","year":"2015","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"key20200713233740_b56-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/path.2595","article-title":"Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer","volume":"219","author":"Song","year":"2009","journal-title":"J Pathol"},{"key":"key20200713233740_b57-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncponc0403","article-title":"Lessons from phase III clinical trials on anti-VEGF therapy for cancer","volume":"3","author":"Jain","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"key20200713233740_b58-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20200713233740_b59-mmr-20-04-3317","first-page":"1278","article-title":"Vascular permeability factor\/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium","volume":"58","author":"Mukhopadhyay","year":"1998","journal-title":"Cancer Res"},{"key":"key20200713233740_b60-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/mc.22718","article-title":"Metformin incombination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivo","volume":"57","author":"Zhang","year":"2018","journal-title":"Mol Carcinog"},{"key":"key20200713233740_b61-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ajo.2007.06.039","article-title":"Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: Applying clinical trial results to the treatment of everyday patients","volume":"144","author":"Brown","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"key20200713233740_b62-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12876-018-0870-3","article-title":"Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2\/RAF\/MEK\/ERK and PI3K\/AKT pathways in cholangiocarcinoma cell","volume":"18","author":"Huang","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"key20200713233740_b63-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1242\/bio.017434","article-title":"VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysis","volume":"5","author":"Fearnley","year":"2016","journal-title":"Biol Open"},{"key":"key20200713233740_b64-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13287-017-0568-4","article-title":"ERK signaling is required for VEGF-A\/VEGFR2-induced differentiation of porcine adipose-derived mesenchymal stem cells into endothelial cells","volume":"8","author":"Almalki","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"key20200713233740_b65-mmr-20-04-3317","doi-asserted-by":"publisher","first-page":"13174","DOI":"10.18632\/oncotarget.14485","article-title":"Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation","volume":"8","author":"Mu","year":"2017","journal-title":"Oncotarget"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T06:39:05Z","timestamp":1664087945000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.10562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":65,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.10562","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]}}}